Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;14(4):317-21.
doi: 10.1007/BF03346823.

Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis

Affiliations

Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis

A Caufriez et al. J Endocrinol Invest. 1991 Apr.

Abstract

To assess the value of serum insulin-like growth factor I (IGF-I) determination in liver disease, 21 patients hospitalized for active alcoholic cirrhosis (19 males, 2 females), 56 +/- 2 y (mean +/- SE) were studied at admission. Individual scores of hepatic alterations (Child score) ranged from 6 to 12 (mean: 9 +/- 1). Basal IGF-I levels were dramatically decreased, averaging 0.11 +/- 0.02 U/ml vs 0.70 +/- 0.08 U/ml in 15 control subjects. In cirrhotic patients, IGF-I values were inversely correlated with the modified Child index (r = 0.57, p less than 0.01). A highly significant positive correlation (r = 0.68, p less than 0.001) was evidenced between IGF-I levels and aminopyrine breath test values (which provide quantitative estimates of the hepatic functional capacity). In contrast, no significant relationship was found between IGF-I levels and various nutritional parameters (albumin, prealbumin, retinol binding protein) after partial correlation analysis. The present data suggest that, in alcoholic cirrhosis, the decrease of circulating IGF-I values is mainly related to alterations of liver function, and that IGF-I can be used as a good indicator of functional hepatocellular capacity.

PubMed Disclaimer

References

    1. Clin Endocrinol (Oxf). 1987 Aug;27(2):183-90 - PubMed
    1. Horm Metab Res. 1984 Dec;16(12):663-6 - PubMed
    1. J Clin Invest. 1977 Sep;60(3):648-57 - PubMed
    1. Metabolism. 1986 Jan;35(1):78-87 - PubMed
    1. J Lab Clin Med. 1988 Nov;112(5):589-94 - PubMed

Publication types

Substances

LinkOut - more resources